Nav Persaud, Canada Research Chair in Health Justice and a staff physician at St
All products ship from BC, Canada with discrete packaging.
One is that the development of DPP-4 inhibition is a rational drug design based in scientific studies on pathophysiology of type 2 diabetes and that the development shows that it is important to target both the impaired insulin secretion and the high glucagon
M2 macrophage-derived exosomal miR-590-3p attenuates DSS-induced mucosal damage and promotes epithelial repair via the LATS1/YAP/ -catenin signalling axis
Building Patient Trust and Continual Care Patients want details about what theyre getting, why youre prescribing it, how youll monitor them, and what happens if anything changes
This selective pathway modulation demonstrates context-dependent signaling intelligence, activating growth pathways while suppressing inflammatory cascades